Use of hyaluronidase for cervical ripening: a randomized trial
- PMID: 16324780
- DOI: 10.1016/j.ejogrb.2005.10.028
Use of hyaluronidase for cervical ripening: a randomized trial
Abstract
Objective: To investigate the action of intracervical administration of hyaluronidase (HAase) as an inductor of cervical ripening on an outpatient basis.
Methods: A randomized double-blind trial was conducted with 168 pregnant women at term, Bishop score (BS)<5, normal fetal vitality and no uterine contractions. An evaluation was performed at the first visit, when either 20,000 UI of lyophilized HAase (5 ml) or placebo was administered via cervical injection. After 48 h, if the BS remained<5, a second dose was administered. The primary outcome was the BS after 48 h or 96 h. The outcome was considered positive when BS>/=5.
Results: The results indicate that the proportion of positive response for the HAase group (55%) after 48 h is significantly higher (p<0.0001) than the corresponding proportion for the placebo group (7%) with an absolute risk reduction (ARR) of 48%=55-7% (95%CI=40-56%). After 96 h, these proportions are 93% in the Haase group and 22% in the placebo group (p<0.0001, ARR=71%, 95%CI=61-81%). The average duration of labour for the nulliparae in the HAase group (6.5h) is significantly smaller (p<0.0001) than for those under placebo (12.0 h) with an absolute difference of 5.5h (95%CI=4.6-6.4h). For the multiparae, the results are 4.3h for the HAase patients versus 9.5h for the placebo patients (p<0.0001) with an absolute difference of 5.2h (95%CI=4.1-6.3h). The proportion of vaginal deliveries for women who received HAase was 82% versus 51% for the placebo group (p=0.0007, ARR=31%, 95%CI=19-44%). The proportion of vaginal deliveries for patients with prior cesareans in the HAase group (69%) was also significantly higher (p<0.0001) than that corresponding to the placebo group (13%) with ARR=56% (95%CI=26-86%). No uterine hyper stimulation occurred in the study.
Conclusion: We detected significant associations between intracervical injection of HAase and ripening of the cervix, as well as with shorter duration of labour and larger chance of vaginal delivery, suggesting that this is a simple, effective and safe method even for women with prior cesarean.
Comment in
-
Comment on Spallicci et al. "Use of hyaluronidase for cervical ripening: a randomized trial" [Eur. J. Obstet. Gynecol. Reprod. Biol. 130 (1) (2007) 46-50].Eur J Obstet Gynecol Reprod Biol. 2009 Feb;142(2):164; author reply 164-5. doi: 10.1016/j.ejogrb.2007.10.019. Epub 2009 Jan 4. Eur J Obstet Gynecol Reprod Biol. 2009. PMID: 19124188 No abstract available.
Similar articles
-
Efficacy and safety of six hourly vaginal misoprostol versus intracervical dinoprostone: a randomized controlled trial.Arch Gynecol Obstet. 2007 Aug;276(2):119-24. doi: 10.1007/s00404-006-0313-1. Arch Gynecol Obstet. 2007. PMID: 17219155 Clinical Trial.
-
Elective cervical ripening in women beyond the 290th day of pregnancy: a randomized trial comparing 2 dinoprostone preparations.J Reprod Med. 2007 Oct;52(10):945-9. J Reprod Med. 2007. PMID: 17977171 Clinical Trial.
-
Induction of labor with mifepristone--a randomized, double-blind study versus placebo.Acta Obstet Gynecol Scand. 1999 Oct;78(9):793-8. Acta Obstet Gynecol Scand. 1999. PMID: 10535343 Clinical Trial.
-
Effectiveness and safety of a new vaginal misoprostol product specifically labeled for cervical ripening and labor induction.Acta Obstet Gynecol Scand. 2006;85(6):706-11. doi: 10.1080/00016340500432580. Acta Obstet Gynecol Scand. 2006. PMID: 16752263 Clinical Trial.
-
Use of uterine EMG and cervical LIF in monitoring pregnant patients.BJOG. 2005 Mar;112 Suppl 1:103-8. doi: 10.1111/j.1471-0528.2005.00596.x. BJOG. 2005. PMID: 15715606 Review.
Cited by
-
Different methods for the induction of labour in outpatient settings.Cochrane Database Syst Rev. 2010 Aug 4;(8):CD007701. doi: 10.1002/14651858.CD007701.pub2. Cochrane Database Syst Rev. 2010. Update in: Cochrane Database Syst Rev. 2017 Sep 13;9:CD007701. doi: 10.1002/14651858.CD007701.pub3. PMID: 20687092 Free PMC article. Updated.
-
Signaling Pathways Regulating Human Cervical Ripening in Preterm and Term Delivery.Cells. 2022 Nov 21;11(22):3690. doi: 10.3390/cells11223690. Cells. 2022. PMID: 36429118 Free PMC article. Review.
-
Cervical remodeling during pregnancy and parturition.Trends Endocrinol Metab. 2010 Jun;21(6):353-61. doi: 10.1016/j.tem.2010.01.011. Epub 2010 Feb 19. Trends Endocrinol Metab. 2010. PMID: 20172738 Free PMC article. Review.
-
Relationships between mechanical properties and extracellular matrix constituents of the cervical stroma during pregnancy.Semin Perinatol. 2009 Oct;33(5):300-7. doi: 10.1053/j.semperi.2009.06.002. Semin Perinatol. 2009. PMID: 19796726 Free PMC article. Review.
-
Pharmacological and mechanical interventions for labour induction in outpatient settings.Cochrane Database Syst Rev. 2017 Sep 13;9(9):CD007701. doi: 10.1002/14651858.CD007701.pub3. Cochrane Database Syst Rev. 2017. PMID: 28901007 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources